Advantage Alpha Capital Partners’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,823
Closed -$626K 180
2024
Q3
$626K Sell
14,823
-7,788
-34% -$371K 0.14% 97
2024
Q2
$1.04M Sell
22,611
-2,377
-10% -$112K 0.23% 84
2024
Q1
$1.3M Sell
24,988
-8,888
-26% -$390K 0.24% 89
2023
Q4
$1.21M Buy
+33,876
New +$1.18M 0.23% 98

Other funds holding VCEL

Advantage Alpha Capital Partners's VCEL Position: Q4 2024 in Review

Advantage Alpha Capital Partners sold out of Vericel Corp (VCEL) in Q4 2024, closing a stake of 14,823 shares — an estimated $626K sold.

Advantage Alpha Capital Partners first reported a position in VCEL in Q4 2023 and held it in 4 quarters. The position peaked at $1.3M in Q1 2024. 278 funds tracked by Wall St. Rank hold VCEL as of Q4 2024.

  • Advantage Alpha Capital Partners reported no remaining Vericel Corp position as of Q4 2024 after selling out during the quarter.
  • Advantage Alpha Capital Partners sold 14,823 Vericel Corp shares in Q4 2024, an estimated $626K.
  • Advantage Alpha Capital Partners first reported a position in Vericel Corp in Q4 2023 and held it in 4 quarters.
  • Advantage Alpha Capital Partners's Vericel Corp position peaked at $1.3M in Q1 2024.
  • 278 funds tracked by Wall St. Rank held Vericel Corp as of Q4 2024.

Based on Advantage Alpha Capital Partners's 13F filing for Q4 2024, filed 11 Feb 2025.